Plus Ultra Leiden

Protinhi Therapeutics selected as part of BLUE KNIGHT™ collaboration for pandemic preparedness

Protinhi Therapeutics, a company specializing in protease inhibition with the aim to combat viral infectious diseases, has announced that it has been selected to join Blue Knight, a global community of early-stage biotech companies.